The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Psychological Distress, Anxiety, and Depression of Cancer‐Affected BRCA1/2 Mutation Carriers: a Systematic Review
Open accessAbstract
Understanding the intermediate‐ and long‐term psychological consequences of genetic testing for cancer patients has led to encouraging research, but a clear consensus of the psychosocial impact and clinical routine for cancer‐affected BRCA1 and BRCA2 mutation carriers is still missing. We performed a systematic review of intermediate‐ and long‐term studies investigating the psychological impact like psychological distress, anxiety, and depression in cancer‐affected BRCA mutation carriers compared to unaffected mutation carriers. This review included the screening of 1243 studies. Eight intermediate‐ and long‐term studies focusing on distress, anxiety, and depression symptoms among cancer‐affected mutation carriers at least six months after the disclosure of genetic testing results were included. Studies reported a great variety of designs, methods, and patient outcomes. We found evidence indicating that cancer‐affected mutation carriers experienced a negative effect in relation to psychological well‐being in terms of an increase in symptoms of distress, anxiety, and depression in the first months after test disclosure. In the intermediate‐ and long‐term, no significant clinical relevant symptoms occurred. However, none of the included studies used specific measurements, which can clearly identify psychological burdens of cancer‐affected mutation carriers. We concluded that current well‐implemented distress screening instruments are not sufficient for precisely identifying the psychological burden of genetic testing. Therefore, future studies should implement coping strategies, specific personality structures, the impact of genetic testing, supportive care needs and disease management behaviour to clearly screen for the possible intermediate‐ and long‐term psychological impact of a positive test disclosure.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“two systematic reviews found higher levels of distress, anxiety, and depression in carriers compared to non-carriers following the announcement of the genetic test result [17, 18].”
From Fear of cancer recurrence in breast cancer survivors carrying a BRCA1 or 2 genetic mutation : a cross-sectional study (2024) · cites this paper as [18]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & the PRISMA Group* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00135 · Cited by 37,554
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-4-200908180-00136 · Cited by 10,349
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
Struewing, J., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,399
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850 · cited 1×
“…University Hospital Tuebingen, Tuebingen, Germany 3 Institute of Medical Genetics and Applied Genomics, University Hospital Tuebingen, Tuebingen, Germany 4 Department of Obstetrics and Gynecology, University Hospital Tuebingen, Tuebingen, Germany 1995; Ford et al. 1994; Struewing et al. 1997).”
BackgroundBreast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602
Anxiety and depression after cancer diagnosis: Prevalence rates by cancer type, gender, and age
Linden, W., Vodermaier, A., MacKenzie, R., & Greig, D. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.03.025 · Cited by 1,245
Research works printed but not linked: 1
- 10.1037/0278-6133.16.1.63 · DOI
Cited by
Sorted by citations
Distress Management, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
Riba, M. B., Donovan, K. A., Andersen, B., Braun, I., Breitbart, W. S., Brewer, B. W., Buchmann, L. O., Clark, M. M., Collins, M., Corbett, C., et al. (2019) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2019.0048 · Cited by 871
Sessa, C., Balmañà, J., Bober, S. L., Cardoso, M. J., Colombo, N., Curigliano, G., Domchek, S. M., Evans, D. G., Fischerová, D., Harbeck, N., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.10.004 · Cited by 324
Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients
Lumish, H. S., Steinfeld, H., Koval, C., Russo, D., Levinson, E., Wynn, J., Duong, J. K., & Chung, W. K. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0090-y · Cited by 118
Psychosocial and behavioral outcomes of genomic testing in cancer: a systematic review
Yanes, T., Willis, A. M., Meiser, B., Tucker, K., & Best, M. C. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-018-0257-5 · Cited by 73
Corso, G., Montagna, G., Figueiredo, J., Vecchia, C. L., Romario, U. F., Fernandes, M. S., Seixas, S., Roviello, F., Trovato, C. M. C., Guerini‐Rocco, E., et al. (2020) · Cancers · doi:10.3390/cancers12061598 · Cited by 61
Metadata
- Authors
- Ringwald, J., Wochnowski, C., Bosse, K., Giel, K. E., Schäffeler, N., Zipfel, S., & Teufel, M.
- Affiliations
- Universitätsklinikum Tübingen (DE)
- Corresponding author
- Ringwald, Johanna
- Venue
- Journal of Genetic Counseling
- Publisher
- Wiley
- Published
- 2016-04-14
- Volume
- 25
- Issue
- 5
- Pages
- 880-891
- ISSN
- 1059-7700 (ISSN-L)
- 1573-3599
- OpenAlex
- W2340539776
- Cited by
- 114
- References
- 59
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 7 · 2023: 20 · 2022: 15 · 2021: 12 · 2020: 11 · 2019: 8 · 2018: 10 · 2017: 4 · 2016: 3
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Genetic Counseling (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Athene programme, Ministry of Science Baden-Wuerttemberg and the European Social Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Psychology › Clinical Psychology › Family Support in Illness
- Keywords
- BRCA1 mutation carriers, BRCA2 mutation carriers, psychological distress, anxiety, depression, cancer patients, psychosocial impact, long-term mental health outcomes, coping strategies, supportive care needs
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Anxiety, Depression, Female, Genetic Testing, Humans, Longitudinal Studies, Male, Middle Aged, Mutation, Neoplasms, Stress, Psychological, BRCA1 Protein, BRCA2 Protein, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
